JP2021063097A5 - - Google Patents

Download PDF

Info

Publication number
JP2021063097A5
JP2021063097A5 JP2020213670A JP2020213670A JP2021063097A5 JP 2021063097 A5 JP2021063097 A5 JP 2021063097A5 JP 2020213670 A JP2020213670 A JP 2020213670A JP 2020213670 A JP2020213670 A JP 2020213670A JP 2021063097 A5 JP2021063097 A5 JP 2021063097A5
Authority
JP
Japan
Prior art keywords
compound
formula
reacted
reacting
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020213670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021063097A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021063097A publication Critical patent/JP2021063097A/ja
Publication of JP2021063097A5 publication Critical patent/JP2021063097A5/ja
Pending legal-status Critical Current

Links

JP2020213670A 2015-08-05 2020-12-23 6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジオール及び6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジアミンを調製する方法 Pending JP2021063097A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562201546P 2015-08-05 2015-08-05
US62/201,546 2015-08-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018505739A Division JP6816106B2 (ja) 2015-08-05 2016-08-04 6−ピリジル−1,3,5−トリアジン−2,4−ジオール及び6−ピリジル−1,3,5−トリアジン−2,4−ジアミンを調製する方法

Publications (2)

Publication Number Publication Date
JP2021063097A JP2021063097A (ja) 2021-04-22
JP2021063097A5 true JP2021063097A5 (https=) 2021-07-26

Family

ID=56684781

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018505739A Active JP6816106B2 (ja) 2015-08-05 2016-08-04 6−ピリジル−1,3,5−トリアジン−2,4−ジオール及び6−ピリジル−1,3,5−トリアジン−2,4−ジアミンを調製する方法
JP2020213670A Pending JP2021063097A (ja) 2015-08-05 2020-12-23 6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジオール及び6−(アリールまたはヘテロアリール)−1,3,5−トリアジン−2,4−ジアミンを調製する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018505739A Active JP6816106B2 (ja) 2015-08-05 2016-08-04 6−ピリジル−1,3,5−トリアジン−2,4−ジオール及び6−ピリジル−1,3,5−トリアジン−2,4−ジアミンを調製する方法

Country Status (8)

Country Link
US (1) US9751863B2 (https=)
EP (1) EP3331866B1 (https=)
JP (2) JP6816106B2 (https=)
CN (1) CN108349933A (https=)
AU (2) AU2016303614A1 (https=)
CA (1) CA2993615A1 (https=)
MX (1) MX365590B (https=)
WO (1) WO2017024134A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017529382A (ja) 2014-09-29 2017-10-05 アギオス ファーマシューティカルス,インコーポレーテッド 治療活性を有する化合物及びその使用方法
JP7220986B6 (ja) 2015-02-04 2024-02-08 アジオス ファーマシューティカルズ, インコーポレイテッド 治療効果のある化合物及びその使用方法
US9751863B2 (en) * 2015-08-05 2017-09-05 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
KR20180063125A (ko) 2015-10-15 2018-06-11 아지오스 파마슈티컬스 아이엔씨. 악성종양을 치료하기 위한 복합 요법
US10695352B2 (en) 2015-10-15 2020-06-30 Celgene Corporation Combination therapy for treating malignancies
ES2905915T3 (es) 2015-12-04 2022-04-12 Servier Lab Procedimientos de tratamiento de neoplasias malignas
MA43640A (fr) 2016-02-26 2018-11-28 Agios Pharmaceuticals Inc Inhibiteurs de idh1 pour le traitement de cancers hématologiques et de tumeurs solides
MX392941B (es) 2016-09-07 2025-03-24 Celgene Corp Composiciones para comprimidos.
WO2018204787A1 (en) 2017-05-05 2018-11-08 Memorial Sloan Kettering Cancer Center Methods of treatment of myeloproliferative neoplasm
US20220017490A1 (en) 2018-11-02 2022-01-20 Celgene Corporation Co-crystals of 2-methyl-1 -[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl) pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol, compositions and methods of use thereof
WO2020092894A1 (en) 2018-11-02 2020-05-07 Celgene Corporation Solid forms of 2-methyl-1-[(4-[6-(trifluoromethyl) pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl) amino]propan-2-ol
US20220017489A1 (en) 2018-11-02 2022-01-20 Celgene Corporation Solid dispersions for treatment of cancer
JP2023503842A (ja) 2019-11-14 2023-02-01 セルジーン コーポレーション がんを処置するための小児用製剤
CN111592524B (zh) * 2020-05-20 2023-11-17 温州市天聚万迅信息科技有限公司 恩西德尼的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390529A (en) 1942-02-03 1945-12-11 Ernst A H Friedheim Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds
JPS5170779A (ja) * 1974-12-17 1976-06-18 Nippon Shinyaku Co Ltd Shinkinaguanamidoruino seiho
JPS58186682A (ja) 1982-04-27 1983-10-31 日本化薬株式会社 セルロ−ス又はセルロ−ス含有繊維材料の染色法
DE3512630A1 (de) 1985-04-06 1986-10-23 Hoechst Ag, 6230 Frankfurt Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern
DE59106971D1 (de) 1990-07-12 1996-01-11 Ciba Geigy Ag Verfahren zur photochemischen und thermischen Stabilisierung von Polyamid-Fasermaterialien.
JPH11158073A (ja) 1997-09-26 1999-06-15 Takeda Chem Ind Ltd アデノシンa3拮抗剤
AU5379900A (en) 1999-06-07 2000-12-28 Shire Biochem Inc. Thiophene integrin inhibitors
EP2256108B1 (en) 2002-07-18 2016-03-23 Janssen Pharmaceutica NV Substituted triazine kinase inhibitors
JP5450381B2 (ja) 2007-04-30 2014-03-26 プロメティック・バイオサイエンスィズ・インコーポレーテッド 化合物、そのような化合物を含有する組成物、及びそのような化合物を用いるがん及び自己免疫疾患の治療法
GB0805477D0 (en) 2008-03-26 2008-04-30 Univ Nottingham Pyrimidines triazines and their use as pharmaceutical agents
WO2010144338A1 (en) 2009-06-08 2010-12-16 Abraxis Bioscience, Llc Triazine derivatives and their therapeutical applications
PE20142098A1 (es) * 2012-01-06 2015-01-08 Agios Pharmaceuticals Inc Compuestos terapeuticamente activos y sus metodos de uso
KR20140131955A (ko) 2012-03-09 2014-11-14 카나 바이오사이언스 인코포레이션 신규 트리아진 유도체
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
AU2014287122B9 (en) 2013-07-11 2018-11-01 Les Laboratoires Servier N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
AU2014295938B2 (en) 2013-08-02 2018-07-19 Les Laboratoires Servier Therapeutically active compounds and their methods of use
JP2017529382A (ja) 2014-09-29 2017-10-05 アギオス ファーマシューティカルス,インコーポレーテッド 治療活性を有する化合物及びその使用方法
JP7220986B6 (ja) 2015-02-04 2024-02-08 アジオス ファーマシューティカルズ, インコーポレイテッド 治療効果のある化合物及びその使用方法
US9751863B2 (en) * 2015-08-05 2017-09-05 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use

Similar Documents

Publication Publication Date Title
JP2021063097A5 (https=)
JP2018528182A5 (https=)
JP2010505926A5 (https=)
PT87552B (pt) Processo para a preparacao de novos derivados de tetrazol utilizaveis como compostos intermedios na preparacao de agentes antihipertensivos
SU659081A3 (ru) Способ получени фенилэтиламинов или их солей
Yan et al. Synthesis of sulfinamides via photocatalytic alkylation or arylation of sulfinylamine
Xu et al. DABCO as a practical catalyst for aromatic halogenation with N-halosuccinimides
Peng et al. Synthesis of 4-alkynylquinazolines: Pd–Cu-cocatalyzed coupling of quinazoline-4-tosylates with terminal alkynes using N-heterocyclic carbenes as ligands
Talukdar et al. Ullmann-Type N-, S-, and O-Arylation Using a Well-Defined 7-Azaindole-N-oxide (7-AINO)-Based Copper (II) Catalyst: Scope and Application to Drug Synthesis
ES2587942T3 (es) Compuestos de fenilimidazol
Turbedaroglu et al. Site-selective C5–H and N–H alkylation of unprotected 8-aminoquinolines
CN109293692A (zh) 一类偕二氟烷基硼酸酯类化合物及其制备方法和应用
JP2021511325A (ja) スルフェントラゾンの合成のための方法
Kobayashi et al. α-Aminoallylation of aldehydes in aqueous ammonia
JP2762430B2 (ja) アラルキルアミノピリミジン類の製法
HU180041B (en) Process for producing 2-bracket-4-furoyl-piperazinyl-bracket closed-4-amino-6,7-dimethoxy-quinasoline derivatives of blood pressure reducing activity
JPS6140266A (ja) ピラゾ−ル誘導体
NO147838B (no) Mellomprodukt til bruk ved fremstilling av det hypotensive middel 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimetoksykinazolin
NO20053928L (no) Fremgangsmate for a fremstille ondansetron og intermediater derav.
US11434224B2 (en) Processes for preparing a diaminopyrimidine derivative or acid addition salt thereof
Mai et al. Visible light-induced cascade N-alkylation/amidation reaction of quinazolin-4 (3 H)-ones and related N-heterocycles
Quan et al. One-Pot Two-Step Synthesis of N3-Functionalized 3, 4-Dihydropyrimidinones in the Presence of TMSCI
JPS5854152B2 (ja) 新規なナフチリジン誘導体
JPS6328068B2 (https=)
CN106220554B (zh) 一种芳基吡啶及其衍生物的制备方法